Mayne Pharma Group Ltd

HG6

Company Profile

  • Business description

    Mayne Pharma Group Ltd is a specialty pharmaceutical company focused on commercializing novel and generic pharmaceuticals It has a Forty-year track record of innovation and success in developing oral drug delivery systems. The Company's Business consists of three operating segments being International, Women’s Health and Dermatology. The Dermatologysegment distributes dermatology products (branded and generic) in the U.S. on a portfolio basis, The Women’s Health segment distributes branded women’s health products in the U.S. International’s segment revenue and gross profit are derived principally from the Australian manufacture and sale of branded and generic pharmaceutical products.

  • Contact

    1538 Main North Road
    Salisbury South
    SalisburySA5106
    AUS

    T: +61 882092666

    https://www.maynepharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Distribution

    Fiscal Year End

    30 June 2026

    Employees

    160

Stocks News & Analysis

stocks

Undervalued ASX share with pathway to positive cash flow

Higher sales and a new loan facility increase our conviction.
stocks

Taiwan Semiconductor earnings: Buoyant guidance backed by voracious AI demand

We’ve raised our fair value estimate of Taiwan Semiconductor stock.
stocks

Ahead of earnings, is Netflix a buy, a sell, or fairly valued?

Watching sales growth and the potential for a major acquisition, here’s what we think of Netflix stock.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,226.7045.900.50%
CAC 408,258.9454.18-0.65%
DAX 4025,297.1355.26-0.22%
Dow JONES (US)49,359.3383.11-0.17%
FTSE 10010,235.293.65-0.04%
HKSE26,844.9678.66-0.29%
NASDAQ23,515.3914.63-0.06%
Nikkei 22553,936.17174.33-0.32%
NZX 50 Index13,718.1058.310.43%
S&P 5006,940.014.46-0.06%
S&P/ASX 2008,903.9048.100.54%
SSE Composite Index4,101.9110.69-0.26%

Market Movers